metricas
covid
Medicina Clínica (English Edition) Ruxolitinib as a bridge to allogeneic hematopoietic cell transplantation in a pa...
Journal Information

Statistics

Follow this link to access the full text of the article

Scientific letter
Ruxolitinib as a bridge to allogeneic hematopoietic cell transplantation in a patient with idiopathic myelofibrosis
Uso de ruxolitinib como tratamiento puente al trasplante alogénico de progenitores hematopoyéticos en un paciente con mielofibrosis idiopática
Pere Barba
Corresponding author
pebarba@vhebron.net

Corresponding author.
, María Laura Fox, Adoración Blanco, David Valcárcel
Servicio de Hematología, Hospital Universitario Vall d’Hebron, Barcelona, Spain
Read
144
Times
was read the article
55
Total PDF
89
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 37 0 37
2017 10 3 1 4
2017 9 5 0 5
2017 8 3 11 14
2017 7 5 4 9
2017 6 8 5 13
2017 5 9 14 23
2017 4 11 7 18
2017 3 5 13 18
2017 2 3 0 3

Follow this link to access the full text of the article

Article options
Tools